Question to the Department of Health and Social Care:
To ask Her Majesty's Government what contingency planning the NHS made to ensure continuity of supply for immunoglobin for patients at the start of the COVID-19 pandemic.
At the start of the COVID-19 pandemic, NHS England and NHS Improvement’s national commissioning criteria for the use of therapeutic immunoglobulin provided expert guidance for the management of patients on immunoglobulin treatment. There is a demand management plan available for use as a contingency to address any instance of constrained supply.
At present, supplies of immunoglobulin are available for patients who require it. An updated demand management plan is currently being developed with updated commissioning criteria to ensure immunoglobulin remains accessible.